6 research outputs found
Proteomic Profile of Human Aortic Stenosis: Insights into the Degenerative Process
Degenerative aortic stenosis is the most common worldwide
cause
of valve replacement. While it shares certain risk factors with coronary
artery disease, it is not delayed or reversed by reducing exposure
to risk factors (e.g., therapies that lower lipids). Therefore, it
is necessary to better understand its pathophysiology for preventive
measures to be taken. In this work, aortic valve samples were collected
from 20 patients that underwent aortic valve replacement (55% males,
mean age of 74 years) and 20 normal control valves were obtained from
necropsies (40% males, mean age of 69 years). The proteome of the
samples was analyzed by quantitative differential electrophoresis
(2D-DIGE) and mass spectrometry, and 35 protein species were clearly
increased in aortic valves, including apolipoprotein AI, alpha-1-antitrypsin,
serum albumin, lumican, alfa-1-glycoprotein, vimentin, superoxide
dismutase CuāZn, serum amyloid P-component, glutathione S-transferase-P,
fatty acid-binding protein, transthyretin, and fibrinogen gamma. By
contrast, 8 protein species were decreased (transgelin, haptoglobin,
glutathione peroxidase 3, HSP27, and calreticulin). All of the proteins
identified play a significant role in cardiovascular processes, such
as fibrosis, homeostasis, and coagulation. The significant changes
observed in the abundance of key cardiovascular proteins strongly
suggest that they can be involved in the pathogenesis of degenerative
aortic stenosis. Further studies are warranted to better understand
this process before we can attempt to modulate it
Proteomics Unravels Extracellular Vesicles as Carriers of Classical Cytoplasmic Proteins in <i>Candida albicans</i>
The
commensal fungus <i>Candida albicans</i> secretes a considerable number of proteins and, as in different
fungal pathogens, extracellular vesicles (EVs) have also been observed.
Our report contains the first proteomic analysis of EVs in <i>C. albicans</i> and a
comparative proteomic
study of the soluble secreted proteins. With this purpose, cell-free
culture supernatants from <i>C. albicans</i> were separated
into EVs and EV-free supernatant and analyzed by LCāMS/MS.
A total of 96 proteins were identified including 75 and 61 proteins
in EVs and EV-free supernatant, respectively. Out of these, 40 proteins
were found in secretome by proteomic analysis for the first time.
The soluble proteins were enriched in cell wall and secreted pathogenesis
related proteins. Interestingly, more than 90% of these EV-free supernatant
proteins were classical secretory proteins with predicted N-terminal
signal peptide, whereas all the leaderless proteins involved in metabolism,
including some moonlighting proteins, or in the exocytosis and endocytosis
process were exclusively cargo of the EVs. We propose a model of the
different mechanisms used by <i>C. albicans</i> secreted
proteins to reach the extracellular medium. Furthermore, we tested
the potential of the Bgl2 protein, identified in vesicles and EV-free
supernatant, to protect against a systemic candidiasis in a murine
model
Proteomic Profile of Human Aortic Stenosis: Insights into the Degenerative Process
Degenerative aortic stenosis is the most common worldwide
cause
of valve replacement. While it shares certain risk factors with coronary
artery disease, it is not delayed or reversed by reducing exposure
to risk factors (e.g., therapies that lower lipids). Therefore, it
is necessary to better understand its pathophysiology for preventive
measures to be taken. In this work, aortic valve samples were collected
from 20 patients that underwent aortic valve replacement (55% males,
mean age of 74 years) and 20 normal control valves were obtained from
necropsies (40% males, mean age of 69 years). The proteome of the
samples was analyzed by quantitative differential electrophoresis
(2D-DIGE) and mass spectrometry, and 35 protein species were clearly
increased in aortic valves, including apolipoprotein AI, alpha-1-antitrypsin,
serum albumin, lumican, alfa-1-glycoprotein, vimentin, superoxide
dismutase CuāZn, serum amyloid P-component, glutathione S-transferase-P,
fatty acid-binding protein, transthyretin, and fibrinogen gamma. By
contrast, 8 protein species were decreased (transgelin, haptoglobin,
glutathione peroxidase 3, HSP27, and calreticulin). All of the proteins
identified play a significant role in cardiovascular processes, such
as fibrosis, homeostasis, and coagulation. The significant changes
observed in the abundance of key cardiovascular proteins strongly
suggest that they can be involved in the pathogenesis of degenerative
aortic stenosis. Further studies are warranted to better understand
this process before we can attempt to modulate it
Proteomic Profile of Human Aortic Stenosis: Insights into the Degenerative Process
Degenerative aortic stenosis is the most common worldwide
cause
of valve replacement. While it shares certain risk factors with coronary
artery disease, it is not delayed or reversed by reducing exposure
to risk factors (e.g., therapies that lower lipids). Therefore, it
is necessary to better understand its pathophysiology for preventive
measures to be taken. In this work, aortic valve samples were collected
from 20 patients that underwent aortic valve replacement (55% males,
mean age of 74 years) and 20 normal control valves were obtained from
necropsies (40% males, mean age of 69 years). The proteome of the
samples was analyzed by quantitative differential electrophoresis
(2D-DIGE) and mass spectrometry, and 35 protein species were clearly
increased in aortic valves, including apolipoprotein AI, alpha-1-antitrypsin,
serum albumin, lumican, alfa-1-glycoprotein, vimentin, superoxide
dismutase CuāZn, serum amyloid P-component, glutathione S-transferase-P,
fatty acid-binding protein, transthyretin, and fibrinogen gamma. By
contrast, 8 protein species were decreased (transgelin, haptoglobin,
glutathione peroxidase 3, HSP27, and calreticulin). All of the proteins
identified play a significant role in cardiovascular processes, such
as fibrosis, homeostasis, and coagulation. The significant changes
observed in the abundance of key cardiovascular proteins strongly
suggest that they can be involved in the pathogenesis of degenerative
aortic stenosis. Further studies are warranted to better understand
this process before we can attempt to modulate it
Proteomics Unravels Extracellular Vesicles as Carriers of Classical Cytoplasmic Proteins in <i>Candida albicans</i>
The
commensal fungus <i>Candida albicans</i> secretes a considerable number of proteins and, as in different
fungal pathogens, extracellular vesicles (EVs) have also been observed.
Our report contains the first proteomic analysis of EVs in <i>C. albicans</i> and a
comparative proteomic
study of the soluble secreted proteins. With this purpose, cell-free
culture supernatants from <i>C. albicans</i> were separated
into EVs and EV-free supernatant and analyzed by LCāMS/MS.
A total of 96 proteins were identified including 75 and 61 proteins
in EVs and EV-free supernatant, respectively. Out of these, 40 proteins
were found in secretome by proteomic analysis for the first time.
The soluble proteins were enriched in cell wall and secreted pathogenesis
related proteins. Interestingly, more than 90% of these EV-free supernatant
proteins were classical secretory proteins with predicted N-terminal
signal peptide, whereas all the leaderless proteins involved in metabolism,
including some moonlighting proteins, or in the exocytosis and endocytosis
process were exclusively cargo of the EVs. We propose a model of the
different mechanisms used by <i>C. albicans</i> secreted
proteins to reach the extracellular medium. Furthermore, we tested
the potential of the Bgl2 protein, identified in vesicles and EV-free
supernatant, to protect against a systemic candidiasis in a murine
model
MOESM1 of Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression
Additional file 1. Figure S1. Representative image of 2D-DIGE gel. Figure S2. Principal component analysis (PCA) graph. Each dot represents a urine sample used in the discovery phase (DIGE analysis). Table S1. Baseline medication for those patients including in the discovery phase. Data are expressed as percentages (%). ACEi: angiotensin converting enzyme inhibitors; ARB: angiotensin receptor blockers. N: normoalbuminuria; dnHA: de novo high albuminuria; MHA: maintained high albuminuria. Table S2. Baseline medication for those patients including in the validation phase. Data are expressed as percentages (%). ACEi: angiotensin converting enzyme inhibitors; ARB: angiotensin receptor blockers. N: normoalbuminuria; dnHA: de novo high albuminuria; MHA: maintained high albuminuria. Table S3. Proteins identifiedper gel spot with significant alteration (one-way ANOVA). The table shows the number of unique peptides identified, % sequence coverage and trends observed for each protein between compared groups (increase or decrease in the group located in the upper part of the ratio). Two spots contain a mixture of two proteins each, thus changes in expression forthose spots cannot be attributed to any of the two proteins initially. When one protein was identified in several spots, observed variations between groups followed the same trend (e.g. CD59 and alpha-1-antitrypsin). Table S4. SRM-LCMS/MS analysis conditions for those proteins confirmed in the validation phase with statistical signification (ANOVA <0.0001). Details of protein transitions (precursor and fragments masses), collision energy and peptide sequences are included